Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12607000208404Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of morphine, parecoxib, ketamine and tramadol in postoperative pain (2 arms), sponsored by Royal Melbourne Hospital. Primary endpoint: Reduced number of respiratory obstructions or desaturations. Planned start Jun 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12607000208404.